Charming Medical Receives Nasdaq Delisting Notice, Faces Nov. 5 Appeal Deadline
Bitget2026/11/05 12:15- Charming Medical received a Nasdaq delisting determination dated October 29, 2026, targeting its securities.
- The decision followed the SEC's November 11, 2025, trading suspension over potential third-party manipulation through social media recommendations.
- Trading will be suspended at the opening on November 9, 2026, unless the company requests an appeal by November 5, 2026.
- Nasdaq will subsequently file to remove the securities from listing and registration; the company is consulting advisers on next steps.
- Nasdaq has identified no company wrongdoing; business operations and financial condition remain unaffected, according to the company.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
